enzastaurin has been researched along with Hepatocellular Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bang, YJ; Jang, IJ; Kim, JR; Kim, W; Kim, YJ; Lee, HS; Yoon, JH | 1 |
| Cui, J; Gao, D; Guo, K; Kang, X; Li, Y; Liu, Y; Sun, L | 1 |
2 other study(ies) available for enzastaurin and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Disease Progression; Drug Synergism; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Situ Nick-End Labeling; Indoles; Liver Neoplasms, Experimental; Lovastatin; Male; Mice; Mice, Inbred C3H; Microvessels; Neoplasm Transplantation; Protein Kinase C; Protein Kinase C beta | 2009 |
Role of PKCbeta in hepatocellular carcinoma cells migration and invasion in vitro: a potential therapeutic target.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Humans; Indoles; Liver Neoplasms; Neoplasm Invasiveness; Neoplasm Metastasis; Oligonucleotide Array Sequence Analysis; Protein Kinase C; Protein Kinase C beta; RNA Interference; Tetradecanoylphorbol Acetate | 2009 |